These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29721644)

  • 21. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
    Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
    Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DNA methylation and cancer].
    Yoshikawa H
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):145-9. PubMed ID: 17301518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis.
    Tommasi S; Zheng A; Yoon JI; Besaratinia A
    Carcinogenesis; 2014 Aug; 35(8):1726-36. PubMed ID: 24480805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D; Hermeking H
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
    Savio AJ; Bapat B
    Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
    Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
    Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental regulation of DNA cytosine methylation at the immunoglobulin heavy chain constant locus.
    Oudinet C; Braikia FZ; Dauba A; Santos JM; Khamlichi AA
    PLoS Genet; 2019 Feb; 15(2):e1007930. PubMed ID: 30779742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic mechanism of rRNA gene silencing: temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation.
    Santoro R; Grummt I
    Mol Cell Biol; 2005 Apr; 25(7):2539-46. PubMed ID: 15767661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells.
    Zschocke J; Allritz C; Engele J; Rein T
    Glia; 2007 May; 55(7):663-74. PubMed ID: 17311293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation and cancer.
    Momparler RL; Bovenzi V
    J Cell Physiol; 2000 May; 183(2):145-54. PubMed ID: 10737890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic alterations in gastric carcinogenesis.
    Choi IS; Wu TT
    Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editing DNA Methylation in the Mammalian Genome.
    Liu XS; Wu H; Ji X; Stelzer Y; Wu X; Czauderna S; Shu J; Dadon D; Young RA; Jaenisch R
    Cell; 2016 Sep; 167(1):233-247.e17. PubMed ID: 27662091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.